Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).
作者信息
Salhotra Amandeep, Aribi Ahmed, Ngo Dat, Zhang Jianying, Sandhu Karamjeet, Al-Malki Monzr, Ali Haris, Koller Paul, Arslan Shukaib, Budde Elizabeth, Khaled Samer, Dadwal Sanjeet, Snyder David S, Artz Andrew, Forman Stephen, Nakamura Ryotaro, Stein Anthony, Marcucci Guido, Aldoss Ibrahim, Pullarkat Vinod
机构信息
Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
Department of Clinical Pharmacology, City of Hope National Medical Center, Duarte, California.
出版信息
Am J Hematol. 2021 Jun 1;96(6):E196-E200. doi: 10.1002/ajh.26157. Epub 2021 Apr 8.
PMID:33719090
Abstract
摘要
Zotero 插件